Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Safety and detailed patterns of morbidity of transrectal ultrasound guided needle biopsy of prostate in a urologist-led unit

  • 85 Accesses

  • 21 Citations

Abstract

Objective: We prospectively evaluate the safety, morbidity and characteristics of complications for transrectal ultrasound guided needle biopsy of prostate carried out solely by urologists in a single unit. This will help to counsel patient prior to the biopsy. Patients and methods: One hundred consecutive patients were recruited to complete questionnaires prospectively, 2 weeks and 3 months after TRUS and prostate biopsy. Haematospermia, haematuria and rectal bleeding characteristics were evaluated. Pain, analgesia requirement, infection and urinary retention rates were also assessed. Results: Ninety-two patients (92%) returned questionnaires 2 weeks and 63 patients (63%) three months after the biopsy. At 2 weeks questionnaire, 58 patients (63%) experienced haematuria and 9 patients (10%) for more than 1 week. Eighty-five percent of the 58 patients who had haematuria described it as mild and intermittent. Twenty-three (25%) patients experienced a rectal bleed and none for more than four days. Only 1 patient experienced clots with the rectal bleeding. Twelve (13%) patients had difficulty passing urine but the symptoms resolved by day four. Acute urinary retention did not occur. Thirty-five (38%) patients had some degree of discomfort and only one patient had pain for more than three days. Twenty-five (27%) patients took analgesia between 1 and 8 days (Mean 3 days). Two patients had a urinary tract infection despite prophylactic antibiotics. At three months, 4 patients (6%) had experienced secondary haematuria 3 weeks after the biopsy. Two patients experienced more rectal bleeding 2 weeks after the biopsy and 1 patient had residual discomfort 2 weeks after the procedure. Thirteen patients (21%) had haematospermia between day 6 and 56 (Mean 21 days). Conclusions: Transrectal ultrasound guided biopsy of the prostate is generally well tolerated with minor pain and morbidity in our urologist-led service. Our data will assist counselling of patients prior to the procedure.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    KK Hodge JE McNeal MK Terris (1989) ArticleTitleRandom systemic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 71 Occurrence Handle2659827 Occurrence Handle1:STN:280:BiaB1c%2FgslY%3D

  2. 2.

    G Aus CG Hermannson J Hugosson et al. (1993) ArticleTitleTranrectal ultrasound examination of prostate: complications and acceptance by patients Br J Urol 71 457 Occurrence Handle8499990 Occurrence Handle1:STN:280:ByyB2s3gvFM%3D Occurrence Handle10.1111/j.1464-410X.1993.tb15992.x

  3. 3.

    KR Ghani D Dundas U Patel (2004) ArticleTitleBleeding after tranrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after six-, eight- and 12-core biopsyprotocol BJU Int 94 IssueID7 1014–1020 Occurrence Handle15541119 Occurrence Handle10.1111/j.1464-410X.2004.05096.x

  4. 4.

    CK Naughton DK Ornstein DS Smith et al. (2000) ArticleTitlePain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomised trial of 6 versus 12 cores J Urol 163 168–171 Occurrence Handle10604338 Occurrence Handle1:STN:280:DC%2BD3c%2FmslyhtQ%3D%3D Occurrence Handle10.1016/S0022-5347(05)67996-7

  5. 5.

    B Djavan M Waldert A Zlotta et al. (2001) ArticleTitleSafety and morbidity of first and repeated transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study J Urol 166 856–860 Occurrence Handle11490233 Occurrence Handle1:STN:280:DC%2BD3MvksVShtg%3D%3D Occurrence Handle10.1016/S0022-5347(05)65851-X

  6. 6.

    CE Lee-Elliott D Dundas U Patel (2004) ArticleTitleRandomised trial of lidocaine vs lidocaine/bupivacaine periprostatic injection on longitudinal pain scores after prostate biopsy J Urol 163 158–162

  7. 7.

    JL Gore SF Shariat BJ Miles et al. (2001) ArticleTitleOptimal combinations of systemic sextant and laterally directed biopsies for the detection of prostate cancer J Urol 165 1554–1559 Occurrence Handle11342916 Occurrence Handle1:STN:280:DC%2BD3M3ovVOitw%3D%3D Occurrence Handle10.1016/S0022-5347(05)66347-1

  8. 8.

    LV Rodriguez MK Terris (1998) ArticleTitleRisk and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature J Urol 160 2115 Occurrence Handle9817335 Occurrence Handle1:STN:280:DyaK1M%2Fjt1antQ%3D%3D Occurrence Handle10.1016/S0022-5347(01)62255-9

  9. 9.

    S Torp-Pedersen F Lee PJ Littrup et al. (1989) ArticleTitleTransrectal biopsy of the prostate guided with trans-rectal US. Longitudinal and multiplanar scanning Radiology 170 23–27 Occurrence Handle2642344 Occurrence Handle1:STN:280:BiaD2s3htVA%3D

  10. 10.

    K Mutaguchi K Shinohara A Matsubara et al. (2005) ArticleTitleLocal anaesthesia during 10 core biopsy of prostate: comparison of 2 methods J Urol 173 742–745 Occurrence Handle15711260 Occurrence Handle10.1097/01.ju.0000152119.28959.3a

  11. 11.

    T Mkinen A Auvinen M Hakama et al. (2002) ArticleTitleAcceptability and complications of prostate biopsy in population based PSA screening versus routine clinical practice: A prospective, controlled study Urology 60 IssueID5 846–850 Occurrence Handle12429313 Occurrence Handle10.1016/S0090-4295(02)01864-2

Download references

Author information

Correspondence to George Lee.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lee, G., Attar, K., Laniado, M. et al. Safety and detailed patterns of morbidity of transrectal ultrasound guided needle biopsy of prostate in a urologist-led unit. Int Urol Nephrol 38, 281–285 (2006). https://doi.org/10.1007/s11255-006-6671-6

Download citation

Keywords

  • Morbidity
  • Prostate biopsy
  • Prostate cancer
  • Safety